Artigos de revistas sobre o tema "GLS1"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "GLS1".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Vidula, Neelima, Christina Yau e Hope S. Rugo. "Glutaminase (GLS) expression in primary breast cancer (BC): Correlations with clinical and tumor characteristics." Journal of Clinical Oncology 37, n.º 15_suppl (20 de maio de 2019): 558. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.558.
Texto completo da fonteRojas, Livisu Pajares, e Claudia Machicado Rivero. "Abstract 883: Glutaminases expression and viral infection as potential prognostic factors in cervical, head and neck and liver cancers". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 883. http://dx.doi.org/10.1158/1538-7445.am2023-883.
Texto completo da fonteBright, Scott J., Rishab Kolachina, Mariam Ben Kacem, Mandira Manandhar, Philip Jones, Timothy A. Yap, Steven H. Lin e Gabriel O. Sawakuchi. "Abstract B030: Modulating mitochondria metabolism to radiosensitize KEAP1 mutated non-small cell lung cancer". Cancer Research 84, n.º 1_Supplement (9 de janeiro de 2024): B030. http://dx.doi.org/10.1158/1538-7445.dnarepair24-b030.
Texto completo da fonteXiao, Yangbo, Rong Huang, Shenping Cao, Dafang Zhao, Zhuangwen Mao, Chuchu Xiao, Zhehua Xu et al. "Molecular Characterization and Dietary Regulation of Glutaminase 1 (gls1) in Triploid Crucian Carp (Carassius auratus)". Fishes 7, n.º 6 (7 de dezembro de 2022): 377. http://dx.doi.org/10.3390/fishes7060377.
Texto completo da fonteMyint, Zin W., Ramon C. Sun, Patrick J. Hensley, Andrew C. James, Peng Wang, Stephen E. Strup, Robert J. McDonald, Donglin Yan, William H. St. Clair e Derek B. Allison. "Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters". Cancers 13, n.º 9 (29 de abril de 2021): 2157. http://dx.doi.org/10.3390/cancers13092157.
Texto completo da fonteYang, Jianqiang, Fanghui Chen, Fan Yang e Yong Teng. "Abstract 3061: A positive feedback loop between GLS1 and c-Myc drives tumor aggressiveness". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 3061. http://dx.doi.org/10.1158/1538-7445.am2024-3061.
Texto completo da fonteAhmed, Shanzay, Peter John, Rehan Zafar Paracha, Attya Bhatti e Monica Guma. "Docking and Molecular Dynamics Study to Identify Novel Phytobiologics from Dracaena trifasciata against Metabolic Reprogramming in Rheumatoid Arthritis". Life 12, n.º 8 (29 de julho de 2022): 1148. http://dx.doi.org/10.3390/life12081148.
Texto completo da fonteKono, Michihito, Nobuya Yoshida, Kayaho Maeda e George C. Tsokos. "Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells". Proceedings of the National Academy of Sciences 115, n.º 10 (20 de fevereiro de 2018): 2478–83. http://dx.doi.org/10.1073/pnas.1714717115.
Texto completo da fonteBeręsewicz-Haller, Małgorzata, Olga Krupska, Paweł Bochomulski, Danuta Dudzik, Anita Chęcińska, Wojciech Hilgier, Coral Barbas, Krzysztof Zablocki e Barbara Zablocka. "Mitochondrial Metabolism behind Region-Specific Resistance to Ischemia-Reperfusion Injury in Gerbil Hippocampus. Role of PKCβII and Phosphate-Activated Glutaminase". International Journal of Molecular Sciences 22, n.º 16 (7 de agosto de 2021): 8504. http://dx.doi.org/10.3390/ijms22168504.
Texto completo da fonteMyint, Zin, Patrick J. Hensley, Andrew Callaway James, Peng Wang, Stephen Strup, Donglin Yan, William H. St Clair, Robert S. DiPaola e Derek B. Allison. "Immunohistochemical evaluation of glutaminase expression in prostate adenocarcinoma and correlation with clinicopathologic parameters." Journal of Clinical Oncology 39, n.º 6_suppl (20 de fevereiro de 2021): 251. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.251.
Texto completo da fonteSyarifin, Andi N. K., Sri W. A. Jusman e Mohamad Sadikin. "Gene expression and enzyme activities of carbonic anhydrase and glutaminase in rat kidneys induced by chronic systemic hypoxia". Medical Journal of Indonesia 24, n.º 3 (9 de novembro de 2015): 139–45. http://dx.doi.org/10.13181/mji.v24i3.1190.
Texto completo da fonteHage, Maha El, Justine Masson, Agnès Conjard-Duplany, Bernard Ferrier, Gabriel Baverel e Guy Martin. "Brain Slices from Glutaminase-Deficient Mice Metabolize Less Glutamine: A Cellular Metabolomic Study with Carbon 13 NMR". Journal of Cerebral Blood Flow & Metabolism 32, n.º 5 (29 de fevereiro de 2012): 816–24. http://dx.doi.org/10.1038/jcbfm.2012.22.
Texto completo da fonteAkar, Hamurcu e Donmez-Altuntas. "The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells". Proceedings 40, n.º 1 (26 de dezembro de 2019): 25. http://dx.doi.org/10.3390/proceedings2019040025.
Texto completo da fonteFu, Jiayao, Yiping Pu, Baoli Wang, Hui Li, Xiujuan Yang, Lisong Xie, Huan Shi et al. "Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren’s Syndrome". Journal of Immunology Research 2022 (15 de fevereiro de 2022): 1–13. http://dx.doi.org/10.1155/2022/3210200.
Texto completo da fonteCoen, Chad, Jizhi Yan, Caner Saygin, Nicole Arellano, Mirielle Nauman, Katarzyna Zawieracz, Daniele Vanni et al. "Glutamine Metabolism Is Altered in Myeloproliferative Neoplasms and Represents a Potential Novel Therapeutic Target". Blood 142, Supplement 1 (28 de novembro de 2023): 6350. http://dx.doi.org/10.1182/blood-2023-189731.
Texto completo da fonteYoshikawa, Sachiko, Manabu Nagao, Ryuji Toh, Masakazu Shinohara, Takuya Iino, Yasuhiro Irino, Makoto Nishimori et al. "Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling". American Journal of Physiology-Heart and Circulatory Physiology 322, n.º 5 (1 de maio de 2022): H749—H761. http://dx.doi.org/10.1152/ajpheart.00692.2021.
Texto completo da fonteFeng, Yifan, Xi Yang, Jinhai Huang, Minqian Shen, Liyang Wang, Xiuping Chen, Yuanzhi Yuan, Chunqiong Dong, Xiaoping Ma e Fei Yuan. "Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages". Oxidative Medicine and Cellular Longevity 2022 (19 de março de 2022): 1–19. http://dx.doi.org/10.1155/2022/1106313.
Texto completo da fonteXu, Lingfan, Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Hong Zhang, Juan Liu et al. "A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer". Proceedings of the National Academy of Sciences 118, n.º 13 (22 de março de 2021): e2012748118. http://dx.doi.org/10.1073/pnas.2012748118.
Texto completo da fonteShibuya, Aya, Neil Margulis, Romain Christiano, Tobias C. Walther e Charles Barlowe. "The Erv41–Erv46 complex serves as a retrograde receptor to retrieve escaped ER proteins". Journal of Cell Biology 208, n.º 2 (12 de janeiro de 2015): 197–209. http://dx.doi.org/10.1083/jcb.201408024.
Texto completo da fonteXiong, Jian, Thi Thu Trang Luu, Kartik Venkatachalam, Guangwei Du e Michael X. Zhu. "Glutamine Produces Ammonium to Tune Lysosomal pH and Regulate Lysosomal Function". Cells 12, n.º 1 (24 de dezembro de 2022): 80. http://dx.doi.org/10.3390/cells12010080.
Texto completo da fonteAbdel-Magid, Ahmed F. "Glutaminase GLS1 Inhibitors as Potential Cancer Treatment". ACS Medicinal Chemistry Letters 7, n.º 3 (fevereiro de 2016): 207–8. http://dx.doi.org/10.1021/acsmedchemlett.6b00016.
Texto completo da fonteGuba, B. S., e V. V. Lyubimov. "Relationship between the effective saturation energy and the amplification diagram of GLS1 and GLS2 neodymium glasses". Soviet Journal of Quantum Electronics 20, n.º 9 (30 de setembro de 1990): 1075–78. http://dx.doi.org/10.1070/qe1990v020n09abeh007407.
Texto completo da fonteLee, You Won, Hun Mi Choi, Seung Yeon Oh, Eun Ji Lee, Kyoung-Ho Pyo, Jae Hwan Kim, Youngseon Byeon et al. "Abstract LB544: Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): LB544. http://dx.doi.org/10.1158/1538-7445.am2022-lb544.
Texto completo da fonteJovanovic, Katarina K., Léa Fléchon, Mairead Reidy, Jihye Park, Xavier Leleu, Irene M. Ghobrial, Thierry Facon, Bruno Quesnel e Salomon Manier. "MYC Overexpressing Multiple Myeloma Are Dependent on GLS1". Blood 134, Supplement_1 (13 de novembro de 2019): 853. http://dx.doi.org/10.1182/blood-2019-128484.
Texto completo da fonteRojo-Báez, Indira, Raymundo S. García-Estrada, Josefina León-Félix, J. Adriana Sañudo-Barajas e Raúl Allende-Molar. "EXPRESIÓN GÉNICA DURANTE EL PROCESO DE INFECCIÓN DE Colletotrichum truncatum (SCHWEIN.) EN PAPAYA MARADOL". Revista Fitotecnia Mexicana 44, n.º 2 (28 de junho de 2021): 221. http://dx.doi.org/10.35196/rfm.2021.2.221.
Texto completo da fonteSponagel, Jasmin, Shanshan Zhang, Prakash Chinnaiyan, Joshua Rubin e Joseph Ippolito. "TBIO-01. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology 22, Supplement_3 (1 de dezembro de 2020): iii467. http://dx.doi.org/10.1093/neuonc/noaa222.830.
Texto completo da fonteLiu, Haixin, Haolun Tian, Pengcheng Hao, Huimin Du, Kun Wang, Yudong Qiu, Xiangrui Yin et al. "PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism". PLOS Pathogens 20, n.º 6 (21 de junho de 2024): e1012305. http://dx.doi.org/10.1371/journal.ppat.1012305.
Texto completo da fonteKim, Sewha, Do Hee Kim, Woo-Hee Jung e Ja Seung Koo. "Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer". Endocrine-Related Cancer 20, n.º 3 (18 de março de 2013): 339–48. http://dx.doi.org/10.1530/erc-12-0398.
Texto completo da fonteSponagel, Jasmin, Shanshan Zhang, Cheryl Frankfater, Jill Jones, Din Selmanovic, Prakash Chinnaiyan, Joshua B. Rubin e Joseph E. Ippolito. "FSMP-19. SEX DIFFERENCES IN REDOX REGULATION UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology Advances 3, Supplement_1 (1 de março de 2021): i19—i20. http://dx.doi.org/10.1093/noajnl/vdab024.082.
Texto completo da fonteChattopadhyaya, Sikta, Raghu Nagalingam, Pavit Narhan e Michael Czubryt. "Regulation of GLS1 Expression by Scleraxis in Cardiac Fibroblasts". FASEB Journal 34, S1 (abril de 2020): 1. http://dx.doi.org/10.1096/fasebj.2020.34.s1.05913.
Texto completo da fonteXia, Xichun, Guangchao Cao, Guodong Sun, Leqing Zhu, Yixia Tian, Yueqi Song, Chengbin Guo et al. "GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis". Journal of Clinical Investigation 130, n.º 10 (24 de agosto de 2020): 5180–96. http://dx.doi.org/10.1172/jci129269.
Texto completo da fonteChen, Weihua, Weifeng Wang, Jun Zhang, Guoqiang Liao, Jie Bai, Bo Yang, Mingyue Tan e Hua Gong. "Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression". Journal of Oncology 2022 (11 de janeiro de 2022): 1–9. http://dx.doi.org/10.1155/2022/7985468.
Texto completo da fonteKrishna, Gayathri, Vinod Soman Pillai e Mohanan Valiya Veettil. "Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein–Barr Virus Infected Cells". Viruses 12, n.º 8 (27 de julho de 2020): 811. http://dx.doi.org/10.3390/v12080811.
Texto completo da fonteNaka, I., J. Saegusa, K. Uto, Y. Yamamoto, Y. Ichise, H. Yamada, K. Akashi et al. "SAT0011 COMBINED INHIBITION OF AUTOPHAGY AND GLUTAMINE METABOLISM SUPPRESSES CELL GROWTH OF RA SYNOVIOCYTES AND AMELIORATES ARTHRITIS IN SKG MICE". Annals of the Rheumatic Diseases 79, Suppl 1 (junho de 2020): 935.2–936. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1661.
Texto completo da fontePoonaki, Elham, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny Apartsin, Sven G. Meuth, Ali Gorji, Christoph Janiak e Ulf Dietrich Kahlert. "CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells". International Journal of Molecular Sciences 23, n.º 10 (13 de maio de 2022): 5479. http://dx.doi.org/10.3390/ijms23105479.
Texto completo da fonteXu, Kangdi, Jun Ding, Lingfeng Zhou, Dazhi Li, Jia Luo, Wenchao Wang, Mingge Shang, Bingyi Lin, Lin Zhou e Shusen Zheng. "SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis". Cells 12, n.º 1 (21 de dezembro de 2022): 25. http://dx.doi.org/10.3390/cells12010025.
Texto completo da fonteLang, Liwei, Fang Wang, Chloe Shay, Yonggang Ke, Nabil Saba e Yong Teng. "Abstract 3026: Inhibition of glutaminolysis overcomes metabolic adaptation to devimistat treatment". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 3026. http://dx.doi.org/10.1158/1538-7445.am2022-3026.
Texto completo da fonteOzcan, Selahattin C., Aydan Mutlu, Tugba H. Altunok, Yunus Gurpinar, Aybike Sarioglu, Sabire Guler, Robertino J. Muchut et al. "Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS-transformed pancreatic cells". Biochemical and Biophysical Research Communications 571 (setembro de 2021): 118–24. http://dx.doi.org/10.1016/j.bbrc.2021.07.070.
Texto completo da fonteXi, Jianbo, Yaocheng Sun, Meiting Zhang, Zhenzhong Fa, Yanya Wan, Zhenyu Min, Hong Xu, Chengkai Xu e Jianjun Tang. "GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway". Experimental Cell Research 381, n.º 1 (agosto de 2019): 1–9. http://dx.doi.org/10.1016/j.yexcr.2019.04.005.
Texto completo da fonteJo, Michiko, Keiichi Koizumi, Mizuho Suzuki, Daisuke Kanayama, Yurie Watanabe, Hiroaki Gouda, Hisashi Mori et al. "Design, synthesis, structure–activity relationship studies, and evaluation of novel GLS1 inhibitors". Bioorganic & Medicinal Chemistry Letters 87 (maio de 2023): 129266. http://dx.doi.org/10.1016/j.bmcl.2023.129266.
Texto completo da fonteOkada, Takuya, Kaho Yamabe, Michiko Jo, Yuko Sakajiri, Tomokazu Shibata, Ryusuke Sawada, Yoshihiro Yamanishi et al. "Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity". Bioorganic & Medicinal Chemistry Letters 93 (setembro de 2023): 129438. http://dx.doi.org/10.1016/j.bmcl.2023.129438.
Texto completo da fonteLam, Elaine T., Lih-Jen Su, Maren Salzmann-Sullivan, Steven K. Nordeen e Thomas W. Flaig. "Preclinical evaluation of teleglenastat (CB-839) in prostate cancer." Journal of Clinical Oncology 41, n.º 6_suppl (20 de fevereiro de 2023): 378. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.378.
Texto completo da fonteLi, Lingzhi, Changying Jiang, Lucy Jayne Navsaria, Yang Liu, Angela Leeming, Michael Wang e Yixin Yao. "Targeting Glutamine Metabolism Overcomes Resistance to Targeted Therapies in Refractory Mantle Cell Lymphoma". Blood 136, Supplement 1 (5 de novembro de 2020): 25–26. http://dx.doi.org/10.1182/blood-2020-140736.
Texto completo da fonteMoncada, Salvador, E. Annie Higgs e Sergio L. Colombo. "Fulfilling the metabolic requirements for cell proliferation". Biochemical Journal 446, n.º 1 (27 de julho de 2012): 1–7. http://dx.doi.org/10.1042/bj20120427.
Texto completo da fonteMatre, Polina, Ismael Samudio, Rodrigo Jacamo, Ying Wang, Jing Wang, R. Eric Davis, Xiaohua Su et al. "Unraveling The Molecular and Metabolic Basis For Glutamine Addiction In Leukemias". Blood 122, n.º 21 (15 de novembro de 2013): 606. http://dx.doi.org/10.1182/blood.v122.21.606.606.
Texto completo da fonteWu, Shuai, Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong, Heng Liu et al. "Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma". Nature Cancer 2, n.º 2 (11 de janeiro de 2021): 189–200. http://dx.doi.org/10.1038/s43018-020-00160-x.
Texto completo da fonteCai, Wei-Feng, Cixiong Zhang, Yu-Qing Wu, Gui Zhuang, Zhiyun Ye, Chen-Song Zhang e Sheng-Cai Lin. "Glutaminase GLS1 senses glutamine availability in a non-enzymatic manner triggering mitochondrial fusion". Cell Research 28, n.º 8 (22 de junho de 2018): 865–67. http://dx.doi.org/10.1038/s41422-018-0057-z.
Texto completo da fonteGao, Chuan-Cheng, Qin-Qin Xu, Feng-Jun Xiao, Hua Wang, Chu-Tse Wu e Li-Sheng Wang. "NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing". Biochemical and Biophysical Research Communications 526, n.º 2 (maio de 2020): 431–38. http://dx.doi.org/10.1016/j.bbrc.2020.03.089.
Texto completo da fonteHenry, Christophe, Dimitri Gorge-Bernat, Pascal Pannier, Isabelle Meaux, Jane Cheng, Fangxian Sun, Olivier Pasquier et al. "Abstract 6033: RA123, a new GLS1 allosteric inhibitor demonstrates in vitro and in vivo activity in multiple myeloma models". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 6033. http://dx.doi.org/10.1158/1538-7445.am2023-6033.
Texto completo da fonteSponagel, Jasmin, Shanshan Zhang, Jill Jones, Prakash Chinnaiyan, Joshua Rubin e Joseph Ippolito. "TAMI-37. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology 22, Supplement_2 (novembro de 2020): ii221. http://dx.doi.org/10.1093/neuonc/noaa215.925.
Texto completo da fonte